We are live on ! Find out more
PHGE icon

BiomX
PHGE

12 hedge funds and large institutions have $1.93M invested in BiomX in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $1.15M → $1.93M (+$780K)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0.01% less ownership

Funds ownership: 0.11% → 0.1% (-0.01%)

8% less funds holding

Funds holding: 13 → 12 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$116K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$51.3K
3
Renaissance Technologies
Renaissance Technologies
New York
+$13K
4
Citadel Advisors
Citadel Advisors
Florida
+$10.1K
5
Walleye Capital
Walleye Capital
New York
+$2.53K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$79.1K
2
MI
MMCAP International
Cayman Islands
-$25.3K
3
Jane Street
Jane Street
New York
-$11.2K
4
UBS Group
UBS Group
Switzerland
-$8.91K
5
TSS
Two Sigma Securities
New York
-$1.98K

PHGE Hedge Fund Activity: Q1 2023 in Review

12 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q1 2023, worth a combined $1.93M — up 68% from $1.15M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHGE and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.

The largest buyer was OrbiMed, adding an estimated $116K. The largest seller was Millennium Management, cutting an estimated $79.1K.

  • 12 institutional investors held BiomX (PHGE) as of Q1 2023, down from 13 in Q4 2022.
  • Funds reported $1.93M of BiomX stock for Q1 2023, up 68% quarter-over-quarter.
  • 1 fund opened new BiomX positions in Q1 2023 and 2 closed out, a net change of -1 holder.
  • The largest BiomX buyer in Q1 2023 was OrbiMed, an estimated $116K added.
  • The largest BiomX seller in Q1 2023 was Millennium Management, an estimated $79.1K sold.

Based on aggregated 13F filings for Q1 2023.